Delivery Order SPE2DE24DA017-SPE2D626F261R
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,665.20 for the Arthrex ACP Double Syringe System on April 24, 2025. This fixed-price contract with economic price adjustment carries an ultimate completion date of April 29, 2025, and will be performed in Naples, Florida. The award was issued by the Defense Logistics Agency's Medical Supply Chain to support the government's orthopedic medical device needs,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $4,950 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain on November 7, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries an ultimate completion date of November 13, 2025. This award was issued without a set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475 on August 6, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment is scheduled for completion by August 11, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain. The contract carries no...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $6,600.00 for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions was awarded on September 23, 2025, with an ultimate completion date of September 26, 2025. The contract was issued without a set-aside designation, reflecting Arthrex's strong competitive position in the federal medical...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 18, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 23, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $1,650 on November 7, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order with economic price adjustment has an ultimate completion date of November 13, 2025, and will be performed at the contractor's Naples, Florida location. The award was made without a set-aside designation, reflecting Arthrex's strong competitive position in federal procurement. The contract is funded through...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, classified as a non-set-aside delivery order with an ultimate completion date of August 22, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F261RDelivery Order
Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $51,760.94 for the Arthrex ACP Double Syringe System on November 18, 2025, with an ultimate completion date of November 21, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for providing medical supplies to Department of Defense and Department of Veterans Affairs healthcare systems. The work will be performed at the contractor's facility in Naples, Florida. This delivery order is issued under Arthrex Inc.'s existing single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million and effective through September 1, 2029. The master contract authorizes procurement of a comprehensive portfolio of orthopedic products and surgical technologies, including surgical implants, arthroscopic instruments, joint replacement systems, and biologics supporting VA medical centers and Department of Defense healthcare facilities nationwide. Arthrex performs as prime contractor with direct relationships to federal agencies and has demonstrated substantial federal contracting capability as a primary supplier to military and veteran healthcare systems across multiple orthopedic surgical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.8k | 11/18/25 |